# ATP6AP1

## Overview
ATP6AP1 is a gene that encodes the ATPase H+ transporting accessory protein 1, also known as Ac45, which is a critical component of the vacuolar H+-ATPase (V-ATPase) complex. This protein functions as an accessory subunit, playing a pivotal role in the acidification of intracellular compartments, a process essential for various cellular activities such as protein degradation and neurotransmitter release (Jansen2016ATP6AP1; Wang2021Prognostic). The V-ATPase complex, to which Ac45 contributes, is composed of two main domains: the V1 domain, responsible for ATP hydrolysis, and the V0 domain, which facilitates proton translocation. Ac45 is particularly involved in directing the V-ATPase to specific subcellular locations, thereby modulating its activity (Jansen2016ATP6AP1). The protein is also implicated in several protein interactions, including its role as an unconventional guanine nucleotide exchange factor (GEF) for the small GTPase Rheb, influencing mTORC1 signaling pathways (Feng2024The). Mutations in ATP6AP1 are linked to various clinical conditions, including congenital disorders of glycosylation and X-linked recessive complex primary immunodeficiency syndrome type 47, highlighting its significance in maintaining cellular homeostasis and function (Tvina2020Prenatal; Semenova2023Clinical).

## Function
The ATP6AP1 gene encodes the Ac45 protein, an accessory subunit of the vacuolar H+-ATPase (V-ATPase) complex, which is essential for the acidification of intracellular compartments such as lysosomes, secretory vesicles, and the Golgi apparatus. This acidification is crucial for various cellular processes, including protein degradation, receptor-mediated endocytosis, and neurotransmitter release (Jansen2016ATP6AP1; Wang2021Prognostic). The V-ATPase complex consists of two domains: V1, responsible for ATP hydrolysis, and V0, which facilitates proton translocation. Ac45 is involved in guiding the V-ATPase into specialized subcellular compartments, such as neuroendocrine secretory vesicles and the osteoclast ruffled border, thereby regulating its activity (Jansen2016ATP6AP1).

In healthy human cells, Ac45 is primarily localized to the early secretory pathway, particularly in liver cells, where it plays a role in intraorganellar pH regulation and is essential for the proper functioning of the V-ATPase complex. This function is critical for processes such as antigen processing and phagolysosome acidification in immune cells (Jansen2016ATP6AP1). Ac45 also influences osteoclast differentiation and function, playing a significant role in extracellular acidification and protease exocytosis, which are essential for bone resorption (Yang2012VATPase).

## Clinical Significance
Mutations in the ATP6AP1 gene are associated with a range of clinical conditions, primarily due to its role in glycosylation and cellular homeostasis. ATP6AP1 mutations lead to congenital disorders of glycosylation (CDG), specifically type II CDG, which result in defects in N-glycosylation and sometimes O-glycosylation. These defects manifest in various organ systems, causing symptoms such as immunodeficiency, hepatopathy, and cognitive impairment (Tvina2020Prenatal; Jansen2016ATP6AP1). 

Patients with ATP6AP1 mutations often present with liver disease, ranging from steatosis to end-stage liver failure, and immune deficiencies like hypogammaglobulinemia, leading to recurrent infections (Tvina2020Prenatal). Neurological symptoms, including epilepsy and intellectual disability, are also common (Semenova2023Clinical). 

The gene's mutations are linked to X-linked recessive complex primary immunodeficiency syndrome type 47 (IMD47), characterized by defective glycosylation of serum proteins and liver dysfunction (Semenova2023Clinical). Other associated conditions include renal tubular acidosis, deafness, osteoporosis, and cancer (Semenova2023Clinical). 

In some cases, ATP6AP1 mutations are implicated in granular cell tumors, where loss-of-function mutations suggest a tumor suppressor role for the gene (Pareja2018Lossoffunction). These mutations lead to decreased V-ATPase activity, resulting in endosomal acidification issues (Pareja2018Lossoffunction).

## Interactions
ATP6AP1, also known as Ac45, is involved in several protein interactions, particularly as a component of the V-ATPase complex. It interacts with all other subunits of the V-ATPase complex, playing a role in processes such as trafficking, folding, assembly, and phosphorylation (Merkulova2015Mapping). ATP6AP1 also interacts with the small GTPase Rheb, acting as an unconventional guanine nucleotide exchange factor (GEF) for Rheb. This interaction is mediated by the C-tail of ATP6AP1, which facilitates the transition of Rheb to its GTP-bound active form, crucial for mTORC1 signaling (Feng2024The).

The C-tail of ATP6AP1 contains specific motifs and residues, such as the Q468 and TISLT motif, which are essential for its interaction with Rheb. Mutations in these regions can significantly reduce or eliminate the interaction (Feng2024The). ATP6AP1's interaction with Rheb is specific and does not extend to other small G proteins like Ras or Rho (Feng2024The).

In osteoclasts, ATP6AP1 interacts with Rab7, a small GTPase involved in vesicular trafficking, suggesting a role in lysosomal trafficking and protease exocytosis (Yang2012VATPase). These interactions highlight ATP6AP1's involvement in critical cellular processes, including mTORC1 signaling and osteoclast-mediated bone resorption.


## References


[1. (Semenova2023Clinical) Natalia Semenova, Olga Shatokhina, Olga Shchagina, Elena Kamenec, Andrey Marakhonov, Anna Degtyareva, Natalia Taran, and Tatiana Strokova. Clinical presentation of a patient with a congenital disorder of glycosylation, type iis (atp6ap1), and liver transplantation. International Journal of Molecular Sciences, 24(8):7449, April 2023. URL: http://dx.doi.org/10.3390/ijms24087449, doi:10.3390/ijms24087449. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms24087449)

[2. (Merkulova2015Mapping) Maria Merkulova, Teodor G. Păunescu, Anie Azroyan, Vladimir Marshansky, Sylvie Breton, and Dennis Brown. Mapping the h+ (v)-atpase interactome: identification of proteins involved in trafficking, folding, assembly and phosphorylation. Scientific Reports, October 2015. URL: http://dx.doi.org/10.1038/srep14827, doi:10.1038/srep14827. This article has 100 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/srep14827)

[3. (Jansen2016ATP6AP1) Eric J. R. Jansen, Sharita Timal, Margret Ryan, Angel Ashikov, Monique van Scherpenzeel, Laurie A. Graham, Hanna Mandel, Alexander Hoischen, Theodore C. Iancu, Kimiyo Raymond, Gerry Steenbergen, Christian Gilissen, Karin Huijben, Nick H. M. van Bakel, Yusuke Maeda, Richard J. Rodenburg, Maciej Adamowicz, Ellen Crushell, Hans Koenen, Darius Adams, Julia Vodopiutz, Susanne Greber-Platzer, Thomas Müller, Gregor Dueckers, Eva Morava, Jolanta Sykut-Cegielska, Gerard J. M. Martens, Ron A. Wevers, Tim Niehues, Martijn A. Huynen, Joris A. Veltman, Tom H. Stevens, and Dirk J. Lefeber. Atp6ap1 deficiency causes an immunodeficiency with hepatopathy, cognitive impairment and abnormal protein glycosylation. Nature Communications, May 2016. URL: http://dx.doi.org/10.1038/ncomms11600, doi:10.1038/ncomms11600. This article has 110 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/ncomms11600)

[4. (Tvina2020Prenatal) Alina Tvina, Allison Thomsen, and Anna Palatnik. Prenatal and postnatal phenotype of a pathologic variant in the atp6ap1 gene. European Journal of Medical Genetics, 63(6):103881, June 2020. URL: http://dx.doi.org/10.1016/j.ejmg.2020.103881, doi:10.1016/j.ejmg.2020.103881. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ejmg.2020.103881)

[5. (Feng2024The) Ran Feng, Feng Liu, Ruofei Li, Zhifen Zhou, Zhuoheng Lin, Song Lin, Shengcheng Deng, Yingying Li, Baoting Nong, Ying Xia, Zhiyi Li, Xiaoqin Zhong, Shuhan Yang, Gang Wan, Wenbin Ma, Su Wu, and Zhou Songyang. The rapid proximity labeling system phastid identifies atp6ap1 as an unconventional gef for rheb. Cell Research, 34(5):355–369, March 2024. URL: http://dx.doi.org/10.1038/s41422-024-00938-z, doi:10.1038/s41422-024-00938-z. This article has 6 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/s41422-024-00938-z)

[6. (Yang2012VATPase) De-Qin Yang, Shengmei Feng, Wei Chen, Haibo Zhao, Christie Paulson, and Yi-Ping Li. V-atpase subunit atp6ap1 (ac45) regulates osteoclast differentiation, extracellular acidification, lysosomal trafficking, and protease exocytosis in osteoclast-mediated bone resorption. Journal of Bone and Mineral Research, 27(8):1695–1707, March 2012. URL: http://dx.doi.org/10.1002/jbmr.1623, doi:10.1002/jbmr.1623. This article has 50 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1002/jbmr.1623)

[7. (Wang2021Prognostic) Jintian Wang, Yunjiang Liu, and Shuo Zhang. Prognostic and immunological value of atp6ap1 in breast cancer: implications for sars-cov-2. Aging, 13(13):16904–16921, July 2021. URL: http://dx.doi.org/10.18632/aging.203229, doi:10.18632/aging.203229. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.18632/aging.203229)

[8. (Pareja2018Lossoffunction) Fresia Pareja, Alissa H. Brandes, Thais Basili, Pier Selenica, Felipe C. Geyer, Dan Fan, Arnaud Da Cruz Paula, Rahul Kumar, David N. Brown, Rodrigo Gularte-Mérida, Barbara Alemar, Rui Bi, Raymond S. Lim, Ino de Bruijn, Sho Fujisawa, Rui Gardner, Elvin Feng, Anqi Li, Edaise M. da Silva, John R. Lozada, Pedro Blecua, Leona Cohen-Gould, Achim A. Jungbluth, Emad A. Rakha, Ian O. Ellis, Maria I. A. Edelweiss, Juan Palazzo, Larry Norton, Travis Hollmann, Marcia Edelweiss, Brian P. Rubin, Britta Weigelt, and Jorge S. Reis-Filho. Loss-of-function mutations in atp6ap1 and atp6ap2 in granular cell tumors. Nature Communications, August 2018. URL: http://dx.doi.org/10.1038/s41467-018-05886-y, doi:10.1038/s41467-018-05886-y. This article has 96 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-018-05886-y)